Table 2.
Univariate logistic regression models for the association between significant variables and improved angiographic findings.
| Univariate logistic regression model | |||
|---|---|---|---|
| Variables | OR | 95% CI | p value |
| Age | 1.01 | (0.92–1.12) | 0.791 |
| Gender | 1.86 | (0.40–8.69) | 0.432 |
| Body height | 1.07 | (0.96–1.20) | 0.237 |
| Body weight | 1.02 | (0.96–1.09) | 0.557 |
| Body mass index | 1.04 | (0.86–1.25) | 0.706 |
| Hypertension | 0.46 | (0.04–4.98) | 0.518 |
| Diabetes mellitus | 1.67 | (0.28–10.09) | 0.578 |
| History or current smoking | 2.00 | (0.44–9.10) | 0.370 |
| Total cholesterol | 0.99 | (0.97–1.01) | 0.242 |
| Low-density lipoprotein | 1.00 | (0.98–1.03) | 0.808 |
| High-density lipoprotein | 0.96 | (0.89–1.03) | 0.236 |
| Previous stroke | 1.43 | (0.22–9.38) | 0.710 |
| Old myocardial infarction | 1.00 | (0.14–7.10) | 1.000 |
| History of CABG | 0.70 | (0.16–3.17) | 0.643 |
| Diffuse multivessel disease | — | — | — |
| Diffuse triple vessel disease | 1.00 | (0.14–7.10) | 1.000 |
| Previous PCI | 0.57 | (0.13–2.50) | 0.458 |
| Aspirin/clopidogrel therapy | — | — | — |
| β-Blocker therapy | 0.77 | (0.09–27.36) | 0.767 |
| Stain therapy | 2.50 | (0.51–12.35) | 0.261 |
| ARB/ACEI therapy | 1.17 | (0.21–6.48) | 0.860 |
| Creatinine level | 3.79 | (0.43–33.72) | 0.232 |
| Creatinine clearance rate | 0.99 | (0.95–1.02) | 0.525 |
| Stage III–IV CKD | 0.89 | (0.20–3.91) | 0.880 |
| Before G-CSF treatment | |||
| KDR+/CD34+/CD45− | 2.26 | (0.02–319.53) | 0.747 |
| CD133+/CD34+/CD45− | 0.001 | (0.00–118.39) | 0.240 |
| CD34+ | 0.85 | (0.39–1.89) | 0.696 |
| After G-CSF treatment | |||
| KDR+/CD34+/CD45− | 0.58 | (0.16–2.13) | 0.409 |
| CD133+/CD34+/CD45− | 0.46 | (0.14–1.49) | 0.197 |
| CD34+ | 0.85 | (0.56–1.28) | 0.430 |
| DIVAA ratio | 3.12 | (1.14–8.55) | 0.027∗ |
∗Defined significant at α = 0.05.